Searchable abstracts of presentations at key conferences in endocrinology

ea0063p988 | Diabetes, Obesity and Metabolism 3 | ECE2019

Effect of high protein diet over caloric expenditure and thermogenesis in individuals with obesity

Lopez Itzel , Figueroa Nicte , Perez Elva , Ibarra Lorena , Martinez Claudia , Malacara Juan

Introduction: The caloric expenditure and thermogenesis are very important aspects in the obesity problem, mostly underestimated. The ‘Protein Leverage Hypothesis’ (PLH) promotes the effect of satiety, delaying the hunger sensation; thus entails the regulation of caloric intake and body weight, as well as, the modification of thermogenic activity and energy expenditure. However, the effect of high protein diet over the physiological components of energy expenditure h...

ea0041ep544 | Diabetes therapy | ECE2016

Potential glycemic overtreatment in diabetics patients older than 70 years and comorbid conditions: real-life experience

Vicente Almudena , Olivar Monica , Cortes Claudia , Martinez Ana , Sastre Julia , Pena Virginia , Canovas Barbara , Lopez Jose

Background: Optimal glucose management in older people is currently unclear. Recent guidelines recommend avoiding tight glycemic targets in elderly patients with comorbidities because intensive control is unlikely to achieve benefit and they are at higher risk of hypoglycaemia.Objective: To estimate the prevalence of potential overtreatment in older adults with diabetes mellitus and comorbidities.Design: Cross-sectional study.<...

ea0037ep1249 | Clinical Cases–Thyroid/Other | ECE2015

Adjustment disorder and hypertensive episodes associated with cross-sex treatment with testosterone

Arnas-Leon Claudia , Martinez-Martin Francisco Javier , Acosta-Calero Carmen , Perdomo-Herrera Esperanza

Introduction: Testosterone treatment in female-to-male transsexuals has been associated with worsened cardiovascular risk factors, acne, male-pattern baldness and more rarely with the onset of hypertension. Another frequent side effect of the treatment is aggression proneness -but rarely actual aggression- and increased libido.Case report: We present the case of a 17-year old transsexual patient referred for initiation of testosterone treatment. A low in...

ea0056ep69 | Diabetes, Obesity and Metabolism | ECE2018

When is it possible to withdraw insulin in patients with type 2 diabetes and multiple cardiovascular risk factors? Can the new drugs be of help?

Ramos-Gomez Isabel , Perez-Ramada Maria Dolores , Santana-Suarez Ana Delia , Nivelo-Rivadeneira Manuel Esteban , Kuzior Agnieszka , Fernandez-Trujillo-Comenge Paula , Acosta-Calero Carmen , Quintana-Arroyo Sara , Arnas-Leon Claudia , Martinez-Martin Francisco Javier

Introduction: Insulin is not an optimal treatment in obese type 2 diabetic patients with insulin resistance. We often introduce it as a last resort hoping to improve the metabolic control of our patients. However it is not always effective, and tends to increase body weight, worsen the global cardiovascular risk and cause hypoglycemias. New drugs such as the GLP-1 agonist receptors can be a better alternative and sometimes allow withdrawal of insulin.Cli...